Estimating Deaths From Cardiovascular Disease: A Review of Global Methodologies of Mortality Measurement
Neha J. Pagidipati(Duke University), Thomas A. Gaziano(Brigham and Women's Hospital)
Cited by 508
Related Papers
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Priority actions for the non-communicable disease crisis
|The Lancet|2011|1.6k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
|The Lancet Diabetes & Endocrinology|2017|591